hyperlipoproteinemia type III
GPTKB entity
Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:alsoKnownAs |
gptkb:familial_dysbetalipoproteinemia
broad beta disease |
| gptkbp:causedBy |
mutation in APOE gene
|
| gptkbp:characterizedBy |
elevated cholesterol
elevated triglycerides presence of beta-VLDL |
| gptkbp:complication |
coronary artery disease
peripheral vascular disease |
| gptkbp:diagnosedBy |
genetic testing
lipid profile |
| https://www.w3.org/2000/01/rdf-schema#label |
hyperlipoproteinemia type III
|
| gptkbp:ICD-10_code |
E78.2
|
| gptkbp:inheritance |
autosomal recessive
|
| gptkbp:MeSH_ID |
D006949
|
| gptkbp:OMIM |
107741
|
| gptkbp:riskFactor |
gptkb:diabetes_mellitus
obesity hypothyroidism estrogen therapy |
| gptkbp:symptom |
gptkb:xanthoma
premature atherosclerosis |
| gptkbp:treatment |
gptkb:fibrates
niacin statins diet modification |
| gptkbp:bfsParent |
gptkb:HGNC:175
gptkb:Apolipoprotein_E_gene gptkb:Apo-E |
| gptkbp:bfsLayer |
7
|